3 COVID-19 vaccine candidates under active consideration of DCGI: Health Ministry
New Delhi: Three COVID-19 vaccines candidates are under active consideration of India’s drug regulator (DCGI), the Union Health Ministry said ...
Read moreDetailsNew Delhi: Three COVID-19 vaccines candidates are under active consideration of India’s drug regulator (DCGI), the Union Health Ministry said ...
Read moreDetailsNew York: Britain became Wednesday the first Western country to approve a COVID-19 vaccine. In the process Britain jumped ahead ...
Read moreDetailsNew Delhi: Serum Institute of India (SII), the world’s largest vaccine manufacturer, denied allegations Tuesday that a COVID-19 trial volunteer ...
Read moreDetailsNew Delhi: The Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in ...
Read moreDetailsNew Delhi: Vaccine major Serum Institute of India Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is ...
Read moreDetailsLondon: AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their experimental ...
Read moreDetailsNew Delhi: Drug firm AstraZeneca India Thursday said it has signed a memorandum of understanding with the Research Society for Study of ...
Read moreDetailsNew Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here Thursday. ...
Read moreDetailsGeneva: "There is now real hope that vaccines, in combination with other tried and tested public health measures, will help ...
Read moreDetailsLondon: Pharmaceutical giants AstraZeneca said Monday its vaccine for the novel coronavirus could be around 90 per cent effective without ...
Read moreDetails